Caxton Associates (New York)’s Cintas CTAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$933K Buy
5,105
+157
+3% +$33K 0.03% 230
2024
Q3
$1.02M Buy
4,948
+2,828
+133% +$546K 0.04% 240
2024
Q2
$371K Buy
+2,120
New +$362K 0.01% 377
2023
Q3
Sell
-7,360
Closed -$915K 446
2023
Q2
$915K Buy
7,360
+1,116
+18% +$131K 0.14% 161
2023
Q1
$722K Buy
+6,244
New +$688K 0.11% 201
2021
Q2
Sell
-5,456
Closed -$466K 487
2021
Q1
$466K Buy
+5,456
New +$462K 0.04% 174
2020
Q2
Sell
-12,684
Closed -$549K 489
2020
Q1
$549K Buy
12,684
+4,416
+53% +$289K 0.1% 142
2019
Q4
$556K Buy
+8,268
New +$544K 0.08% 154
2018
Q3
Sell
-11,012
Closed -$509K 426
2018
Q2
$509K Buy
+11,012
New +$496K 0.03% 240

Other funds holding CTAS

Caxton Associates (New York)'s CTAS Position: Q4 2024 in Review

Caxton Associates (New York) increased its Cintas (CTAS) stake by 3.2% in Q4 2024, buying an estimated $33K and bringing the position to 5,105 shares worth $933K. The position accounts for 0.03% of the portfolio, ranked #230.

Caxton Associates (New York) first reported a position in CTAS in Q2 2018 and has held it in 9 quarters since. The position peaked at $1.02M in Q3 2024. 1,388 funds tracked by Wall St. Rank hold CTAS as of Q4 2024.

  • Caxton Associates (New York) held 5,105 shares of Cintas worth $933K as of Q4 2024.
  • Caxton Associates (New York) bought 157 Cintas shares in Q4 2024, an estimated $33K.
  • Cintas made up 0.03% of Caxton Associates (New York)'s portfolio in Q4 2024, its #230 holding.
  • Caxton Associates (New York) first reported a position in Cintas in Q2 2018 and has held it in 9 quarters since.
  • Caxton Associates (New York)'s Cintas position peaked at $1.02M in Q3 2024.
  • 1,388 funds tracked by Wall St. Rank held Cintas as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.